A detailed history of Chris Bulman Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Chris Bulman Inc holds 369 shares of LLY stock, worth $306,838. This represents 0.22% of its overall portfolio holdings.

Number of Shares
369
Previous 271 36.16%
Holding current value
$306,838
Previous $246 Million 33.21%
% of portfolio
0.22%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $75,669 - $94,081
98 Added 36.16%
369 $327 Million
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $196,439 - $246,349
271 New
271 $246 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $790B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chris Bulman Inc Portfolio

Follow Chris Bulman Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chris Bulman Inc, based on Form 13F filings with the SEC.

News

Stay updated on Chris Bulman Inc with notifications on news.